These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 15846269

  • 1. Clinical factors associated with abandonment of a rate-control or a rhythm-control strategy for the management of atrial fibrillation in the AFFIRM study.
    Curtis AB, Seals AA, Safford RE, Slater W, Tullo NG, Vidaillet H, Wilber DJ, Slee A.
    Am Heart J; 2005 Feb; 149(2):304-8. PubMed ID: 15846269
    [Abstract] [Full Text] [Related]

  • 2. Clinical factors that influence response to treatment strategies in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
    Curtis AB, Gersh BJ, Corley SD, DiMarco JP, Domanski MJ, Geller N, Greene HL, Kellen JC, Mickel M, Nelson JD, Rosenberg Y, Schron E, Shemanski L, Waldo AL, Wyse DG, AFFIRM Investigators.
    Am Heart J; 2005 Apr; 149(4):645-9. PubMed ID: 15990747
    [Abstract] [Full Text] [Related]

  • 3. Functional status in rate- versus rhythm-control strategies for atrial fibrillation: results of the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Functional Status Substudy.
    Chung MK, Shemanski L, Sherman DG, Greene HL, Hogan DB, Kellen JC, Kim SG, Martin LW, Rosenberg Y, Wyse DG, AFFIRM Investigators.
    J Am Coll Cardiol; 2005 Nov 15; 46(10):1891-9. PubMed ID: 16286177
    [Abstract] [Full Text] [Related]

  • 4. Relation of initial resting ventricular rate to the ability to achieve and maintain normal sinus rhythm in patients with atrial fibrillation.
    Cooper HA, Sacco J, Solomon AJ, Feld GK, Leman R, Wilber D, AFFIRM Investigators.
    Am J Cardiol; 2005 Mar 01; 95(5):597-602. PubMed ID: 15721098
    [Abstract] [Full Text] [Related]

  • 5. Occurrence and characteristics of stroke events in the Atrial Fibrillation Follow-up Investigation of Sinus Rhythm Management (AFFIRM) study.
    Sherman DG, Kim SG, Boop BS, Corley SD, Dimarco JP, Hart RG, Haywood LJ, Hoyte K, Kaufman ES, Kim MH, Nasco E, Waldo AL, National Heart, Lung, and Blood Institute AFFIRM Investigators.
    Arch Intern Med; 2005 May 23; 165(10):1185-91. PubMed ID: 15911734
    [Abstract] [Full Text] [Related]

  • 6. AFFIRM and RACE trials: implications for the management of atrial fibrillation.
    Blackshear JL, Safford RE, AFFIRM trial, RACE trial.
    Card Electrophysiol Rev; 2003 Dec 23; 7(4):366-9. PubMed ID: 15071255
    [Abstract] [Full Text] [Related]

  • 7. Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
    DiMarco JP, Flaker G, Waldo AL, Corley SD, Greene HL, Safford RE, Rosenfeld LE, Mitrani G, Nemeth M, AFFIRM Investigators.
    Am Heart J; 2005 Apr 23; 149(4):650-6. PubMed ID: 15990748
    [Abstract] [Full Text] [Related]

  • 8. Atrial fibrillation: rhythm control offers no advantage over rate control for some, but not all.
    Li YB, Hu CL, Liu J, Chen YX, Qu Z, Xu JL, Chen JB, Wan J, Tang QZ, Huang CX.
    Med Hypotheses; 2007 Apr 23; 69(1):206-8. PubMed ID: 17011138
    [Abstract] [Full Text] [Related]

  • 9. Quality of life in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
    Jenkins LS, Brodsky M, Schron E, Chung M, Rocco T, Lader E, Constantine M, Sheppard R, Holmes D, Mateski D, Floden L, Prasun M, Greene HL, Shemanski L.
    Am Heart J; 2005 Jan 23; 149(1):112-20. PubMed ID: 15660042
    [Abstract] [Full Text] [Related]

  • 10. Comparison of rate versus rhythm control for atrial fibrillation in patients with left ventricular dysfunction (from the AFFIRM Study).
    Freudenberger RS, Wilson AC, Kostis JB, AFFIRM Investigators and Committees.
    Am J Cardiol; 2007 Jul 15; 100(2):247-52. PubMed ID: 17631079
    [Abstract] [Full Text] [Related]

  • 11. Rate vs rhythm control in patients with atrial fibrillation: a meta-analysis.
    de Denus S, Sanoski CA, Carlsson J, Opolski G, Spinler SA.
    Arch Intern Med; 2005 Feb 14; 165(3):258-62. PubMed ID: 15710787
    [Abstract] [Full Text] [Related]

  • 12. Rationale and design of a study assessing treatment strategies of atrial fibrillation in patients with heart failure: the Atrial Fibrillation and Congestive Heart Failure (AF-CHF) trial.
    Am Heart J; 2002 Oct 14; 144(4):597-607. PubMed ID: 12360154
    [Abstract] [Full Text] [Related]

  • 13. Analysis of cause-specific mortality in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
    Steinberg JS, Sadaniantz A, Kron J, Krahn A, Denny DM, Daubert J, Campbell WB, Havranek E, Murray K, Olshansky B, O'Neill G, Sami M, Schmidt S, Storm R, Zabalgoitia M, Miller J, Chandler M, Nasco EM, Greene HL.
    Circulation; 2004 Apr 27; 109(16):1973-80. PubMed ID: 15051639
    [Abstract] [Full Text] [Related]

  • 14. Asymptomatic atrial fibrillation: demographic features and prognostic information from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
    Flaker GC, Belew K, Beckman K, Vidaillet H, Kron J, Safford R, Mickel M, Barrell P, AFFIRM Investigators.
    Am Heart J; 2005 Apr 27; 149(4):657-63. PubMed ID: 15990749
    [Abstract] [Full Text] [Related]

  • 15. Rhythm versus rate control in the contemporary management of atrial fibrillation in-hospital.
    Allen Lapointe NM, Sun JL, Kaplan S, d'Almada P, Al-Khatib SM.
    Am J Cardiol; 2008 Apr 15; 101(8):1134-41. PubMed ID: 18394447
    [Abstract] [Full Text] [Related]

  • 16. The RecordAF study: design, baseline data, and profile of patients according to chosen treatment strategy for atrial fibrillation.
    Le Heuzey JY, Breithardt G, Camm J, Crijns H, Dorian P, Kowey PR, Merioua I, Prystowsky EN, Schwartz PJ, Torp-Pedersen C, Weintraub W.
    Am J Cardiol; 2010 Mar 01; 105(5):687-93. PubMed ID: 20185018
    [Abstract] [Full Text] [Related]

  • 17. A randomised, controlled study of rate versus rhythm control in patients with chronic atrial fibrillation and heart failure: (CAFE-II Study).
    Shelton RJ, Clark AL, Goode K, Rigby AS, Houghton T, Kaye GC, Cleland JG.
    Heart; 2009 Jun 01; 95(11):924-30. PubMed ID: 19282313
    [Abstract] [Full Text] [Related]

  • 18. Gender-related differences in rhythm control treatment in persistent atrial fibrillation: data of the Rate Control Versus Electrical Cardioversion (RACE) study.
    Rienstra M, Van Veldhuisen DJ, Hagens VE, Ranchor AV, Veeger NJ, Crijns HJ, Van Gelder IC, RACE Investigators.
    J Am Coll Cardiol; 2005 Oct 04; 46(7):1298-306. PubMed ID: 16198847
    [Abstract] [Full Text] [Related]

  • 19. Mending the rhythm does not improve prognosis in patients with persistent atrial fibrillation: a subanalysis of the RACE study.
    Rienstra M, Van Gelder IC, Hagens VE, Veeger NJ, Van Veldhuisen DJ, Crijns HJ.
    Eur Heart J; 2006 Feb 04; 27(3):357-64. PubMed ID: 16275661
    [Abstract] [Full Text] [Related]

  • 20. Management of atrial fibrillation.
    Hersi A, Wyse DG.
    Curr Probl Cardiol; 2005 Apr 04; 30(4):175-233. PubMed ID: 15778690
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.